{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T14:40:02Z","timestamp":1784990402909,"version":"3.55.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.pbb.2016.09.009","type":"journal-article","created":{"date-parts":[[2016,10,2]],"date-time":"2016-10-02T06:17:26Z","timestamp":1475389046000},"page":"87-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Acute buspirone dosing enhances abuse-related subjective effects of oral methamphetamine"],"prefix":"10.1016","volume":"150-151","author":[{"given":"Erika","family":"Pike","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William W.","family":"Stoops","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig R.","family":"Rush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2016.09.009_bb0005","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.drugalcdep.2015.01.036","article-title":"Bupropion for the treatment of methamphetamine dependence in non-daily users: a randomized, double-blind, placebo-controlled trial","volume":"150","author":"Anderson","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.pbb.2016.09.009_bb0010","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1017\/S1461145712000661","article-title":"Modification of cocaine self-administration by buspirone (buspar\u00ae): potential involvement of D3 and D4 dopamine receptors","volume":"16","author":"Bergman","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.pbb.2016.09.009_bb0015","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/dar.12048","article-title":"Pharmacotherapy of amphetamine-type stimulant dependence: an update","volume":"32","author":"Brensilver","year":"2013","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.pbb.2016.09.009_bb0020","series-title":"2014 National Survey on Drug Use and Health: Detailed Tables","author":"Center for Behavioral Health Statistics and Quality","year":"2015"},{"key":"10.1016\/j.pbb.2016.09.009_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2008.03.001","article-title":"The role of human drug self-administration procedures in the development of medications","volume":"96","author":"Comer","year":"2008","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.pbb.2016.09.009_bb0030","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.drugalcdep.2014.08.003","article-title":"Methamphetamine: an update on epidemiology, pharmacology, clinical phenomenology, and treatment literature","volume":"143","author":"Courtney","year":"2014","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.pbb.2016.09.009_bb0035","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1038\/npp.2014.300","article-title":"Effects of oral and intravenous administration of buspirone on food-cocaine choice in socially housed male cynomolgus monkeys","volume":"40","author":"Czoty","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2016.09.009_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0002-9343(86)90325-6","article-title":"Buspirone: review of its pharmacology and current perspectives on its mechanism of action","volume":"80","author":"Eison","year":"1986","journal-title":"Am. J. Med."},{"key":"10.1016\/j.pbb.2016.09.009_bb0045","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/08897070802218554","article-title":"Pharmacotherapy of methamphetamine addiction: an update","volume":"29","author":"Elkashef","year":"2008","journal-title":"Subst. Abus."},{"key":"10.1016\/j.pbb.2016.09.009_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(00)00639-7","article-title":"Differential effects of stimulants on monoaminergic transporters: pharmacological consequences and implications for neurotoxicity","volume":"406","author":"Fleckenstein","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2016.09.009_bb0055","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1146\/annurev.pharmtox.47.120505.105140","article-title":"New insights into the mechanism of action of amphetamines","volume":"47","author":"Fleckenstein","year":"2007","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.pbb.2016.09.009_bb0060","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/00008877-199402000-00009","article-title":"Effects of buprenorphine on the self-administration of cocaine by humans","volume":"5","author":"Foltin","year":"1994","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.pbb.2016.09.009_bb0065","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/clpt.2010.307","article-title":"A randomized, placebo-controlled trial of sustained-release dextroamphetamine for treatment of methamphetamine addiction","volume":"89","author":"Galloway","year":"2011","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.pbb.2016.09.009_bb0070","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/BF02245114","article-title":"Effects of buspirone and gepirone on i.v. cocaine self-administration in rhesus monkeys","volume":"108","author":"Gold","year":"1992","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2016.09.009_bb0075","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00213-008-1079-x","article-title":"Controversies in translational research: drug self-administration","volume":"199","author":"Haney","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2016.09.009_bb0080","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s002130100725","article-title":"Effects of ecopipam, a selective dopamine D1 antagonist, on smoked cocaine self-administration by humans","volume":"155","author":"Haney","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2016.09.009_bb0085","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s002130100738","article-title":"Methamphetamine self-administration by humans","volume":"157","author":"Hart","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2016.09.009_bb0090","doi-asserted-by":"crossref","first-page":"410","DOI":"10.2174\/187152708786927822","article-title":"Selective antagonism at dopamine D3 receptors as a target for drug addiction pharmacotherapy: a review of preclinical evidence","volume":"7","author":"Heidbreder","year":"2008","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.pbb.2016.09.009_bb0095","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0091-3057(94)90554-1","article-title":"Dopamine receptor antagonists block amphetamine and phencyclidine-induced motor stimulations in rats","volume":"48","author":"Jackson","year":"1994","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2016.09.009_bb0100","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s00213-014-3760-6","article-title":"Effects of buspirone and the dopamine D3 receptor compound PG619 on cocaine and methamphetamine self-administration in rhesus monkeys using a food-drug choice paradigm","volume":"232","author":"John","year":"2015","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2016.09.009_bb0105","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00213-011-2383-4","article-title":"A direct comparison of the behavioral and physiological effects of methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) in humans","volume":"219","author":"Kirkpatrick","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2016.09.009_bb0110","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s00213-008-1346-x","article-title":"Brain serotonin transporter in human methamphetamine users","volume":"202","author":"Kish","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2016.09.009_bb0115","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF02090784","article-title":"S-(+)-aporphines are not selective for human D3 dopamine receptors","volume":"14","author":"Kula","year":"1994","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.pbb.2016.09.009_bb0120","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1111\/add.12608","article-title":"Sustained-release methylphenidate in a randomized trial of treatment of methamphetamine use disorder","volume":"109","author":"Ling","year":"2014","journal-title":"Addiction"},{"key":"10.1016\/j.pbb.2016.09.009_bb0125","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2165\/00003088-199936040-00003","article-title":"Clinical pharmacokinetics and pharmacodynamics of buspirone, an anxiolytic drug","volume":"36","author":"Mahmood","year":"1999","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.pbb.2016.09.009_bb0130","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/0006-2952(76)90432-9","article-title":"Inhibition of monoamine oxidase by amphetamine and related compounds","volume":"25","author":"Mantle","year":"1976","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.pbb.2016.09.009_bb0135","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3758\/BF03203313","article-title":"An automated version of the digit symbol substitution test (DSST)","volume":"14","author":"McLeod","year":"1982","journal-title":"Behav. Res. Methods Instrum. Comput."},{"key":"10.1016\/j.pbb.2016.09.009_bb0140","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/npp.2012.202","article-title":"Effects of chronic buspirone treatment on cocaine self-administration","volume":"38","author":"Mello","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2016.09.009_bb0145","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/00008877-199410000-00004","article-title":"Blockade of the discriminative effects of d-amphetamine in rhesus monkeys with serotonin 5-HT(1A) agonists","volume":"5","author":"Nader","year":"1994","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.pbb.2016.09.009_bb0150","series-title":"Epidemiologic Trends in Drug Abuse: Proceedings of the Community Epidemiology Work Group, Highlights and Executive Summary. US Department of Health and Human Services","author":"National Institute on Drug Abuse (NIDA)","year":"2014"},{"key":"10.1016\/j.pbb.2016.09.009_bb0155","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1038\/sj.npp.1300979","article-title":"Bupropion reduces methamphetamine-induced subjective effects and cue-induced craving","volume":"31","author":"Newton","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2016.09.009_bb0160","series-title":"The Economic Cost of Methamphetamine Use in the United States, 2005","author":"Nicosia","year":"2009"},{"key":"10.1016\/j.pbb.2016.09.009_bb0165","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0022-3565(25)11160-9","article-title":"Caffeine drug discrimination in humans: acquisition, specificity and correlation with self-reports","volume":"261","author":"Oliveto","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2016.09.009_bb0170","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1080\/00952990701522732","article-title":"Methamphetamine users in the psychiatric emergency services: a case-control study","volume":"33","author":"Pasic","year":"2007","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.pbb.2016.09.009_bb0175","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/JCP.0000000000000207","article-title":"Methamphetamine self-administration in humans during d-amphetamine maintenance","volume":"34","author":"Pike","year":"2014","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.pbb.2016.09.009_bb0180","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1001\/archpsyc.56.12.1101","article-title":"Attenuation of the euphoric effects of cocaine by the dopamine D1\/D5 antagonist ecopipam (SCH 39166)","volume":"56","author":"Romach","year":"1999","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pbb.2016.09.009_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02740680","article-title":"A review of the effects of dopaminergic agents on humans, animals, and drug-seeking behavior, and its implications for medication development. Focus on GBR 12909","volume":"11","author":"Rothman","year":"1995","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.pbb.2016.09.009_bb0190","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/01.jcp.0000130553.55630.ad","article-title":"Alprazolam attenuates the behavioral effects of d-amphetamine in humans","volume":"24","author":"Rush","year":"2004","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.pbb.2016.09.009_bb0200","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00213-010-2067-5","article-title":"Subjective and physiological effects of acute intranasal methamphetamine during d-amphetamine maintenance","volume":"214","author":"Rush","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2016.09.009_bb0195","series-title":"Pharmacology and Treatment of Substance Abuse: Evidence- and Outcome-Based Perspectives","first-page":"335","article-title":"Evidence-based treatment of amphetamine dependence: behavioral and pharmacological approaches","author":"Rush","year":"2009"},{"key":"10.1016\/j.pbb.2016.09.009_bb0205","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1176\/appi.ajp.160.9.1699","article-title":"Association of dopamine transporter loss in the orbitofrontal and dorsolateral prefrontal cortices with methamphetamine-related psychiatric symptoms","volume":"160","author":"Sekine","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pbb.2016.09.009_bb0210","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/JCP.0b013e318221b2db","article-title":"Discriminative-stimulus, subject rated, and physiological effects of methamphetamine in humans pretreated with aripiprazole","volume":"31","author":"Sevak","year":"2011","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.pbb.2016.09.009_bb0215","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.drugalcdep.2008.03.010","article-title":"Randomized, placebo-controlled trial of bupropion for the treatment of methamphetamine dependence","volume":"96","author":"Shoptaw","year":"2008","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.pbb.2016.09.009_bb0220","series-title":"The Cochrane Database of Systematic Reviews","article-title":"Treatment for amphetamine withdrawal","author":"Shoptaw","year":"2009"},{"key":"10.1016\/j.pbb.2016.09.009_bb0225","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/j.1875-9114.1984.tb03384.x","article-title":"Preclinical pharmacology of buspirone hydrochloride","volume":"4","author":"Skolnick","year":"1984","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.pbb.2016.09.009_bb0230","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1111\/j.1360-0443.2011.03766.x","article-title":"Influence of acute bupropion pre-treatment on the effects of intranasal cocaine","volume":"107","author":"Stoops","year":"2012","journal-title":"Addiction"},{"key":"10.1016\/j.pbb.2016.09.009_bb0235","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.pbb.2014.11.018","article-title":"Naltrexone and bupropion, alone or combined, do not alter the reinforcing effects of intranasal methamphetamine","volume":"129","author":"Stoops","year":"2015","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2016.09.009_bb0240","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1176\/ajp.2007.164.1.160","article-title":"A comparison of aripiprazole, methylphenidate, and placebo for amphetamine dependence","volume":"164","author":"Tiihonen","year":"2007","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pbb.2016.09.009_bb0245","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1600-0773.1991.tb01289.x","article-title":"Molecular basis of buspirone's anxiolytic action","volume":"69","author":"Tunnicliff","year":"1991","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.pbb.2016.09.009_bb0255","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/npp.2011.84","article-title":"New medications for substance use disorders: challenges and opportunities","volume":"37","author":"Volkow","year":"2012","journal-title":"Neuropsychopharmacology"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305716301630?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305716301630?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T22:19:43Z","timestamp":1749593983000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305716301630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":50,"alternative-id":["S0091305716301630"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2016.09.009","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute buspirone dosing enhances abuse-related subjective effects of oral methamphetamine","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2016.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}